表紙:バーチャル治験の世界市場の分析 (2022年)
市場調査レポート
商品コード
1107237

バーチャル治験の世界市場の分析 (2022年)

Virtual Clinical Trials Global Market Report 2022

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
バーチャル治験の世界市場の分析 (2022年)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

世界のバーチャル治験市場は、2021年の88億5,000万米ドルから、8.68%のCAGRで成長し、2022年には96億1,000万米ドルにまで拡大すると予測されます。バーチャル治験市場は、7.75%のCAGRで成長し、2026年に129億6,000万米ドルに達すると予測されます。

2021年のバーチャル治験市場では、北米が最大の地域となりました。アジア太平洋は予測期間中に最も成長する地域であると予想されます。

政府や製薬会社による新ワクチンや新薬の開発のための研究開発への投資の増加が、バーチャル治験市場の成長を促進しています。医療業界の研究開発部門は、医薬品やその製品の品質保証や臨床データ管理を強化するために、バーチャル治験のソリューションやサービスを活用するようになってきています。

技術進歩は、バーチャル治験市場で人気を博している主要な動向です。バーチャル治験市場で事業を展開する主要企業は、急成長する業界の需要に対応し、市場での地位を強化するために、技術的に高度なソリューションの提供に注力しています。

目次

第1章 エグゼクティブサマリー

第2章 バーチャル治験市場の特徴

第3章 バーチャル治験市場の傾向と戦略

第4章 バーチャル治験市場:新型コロナウイルス感染症 (COVID-19) の影響

第5章 バーチャル治験市場:市場規模・成長率

  • 過去の市場 (金額、2016年~2021年)
    • 市場促進要因
    • 市場抑制要因
  • 市場の予測 (金額、2021年~2026年、2031年)
    • 市場促進要因
    • 市場抑制要因

第6章 バーチャル治験市場の内訳

  • 設計別の市場区分 (金額、2016年~2021年、2021年~2026年、2031年)
    • 観察試験
    • 介入試験
    • 拡張参加試験
  • フェーズ別の市場区分 (金額、2016年~2021年、2021年~2026年、2031年)
    • フェーズ I
    • フェーズ II
    • フェーズ III
    • フェーズ IV
  • 適応症別の市場区分 (金額、2016年~2021年、2021年~2026年、2031年)
    • CNS (中枢神経系)
    • 自己免疫疾患/炎症
    • 循環器
    • 代謝・内分泌疾患
    • 感染症
    • 腫瘍
    • 泌尿生殖器
    • 眼科
    • その他

第7章 バーチャル治験市場:地域別・国別分析

  • 地域別の市場区分 (金額、2016年~2021年、2021年~2026年、2031年)
  • 国別の市場区分 (金額、2016年~2021年、2021年~2026年、2031年)

第8章 アジア太平洋のバーチャル治験市場

  • 市場概要
  • 地域情報
  • 設計別の市場区分 (金額、2016年~2021年、2021年~2026年、2031年)
  • 適応症別の市場区分 (金額、2016年~2021年、2021年~2026年、2031年)

第9章 中国のバーチャル治験市場

第10章 インドのバーチャル治験市場

第11章 日本のバーチャル治験市場

第12章 オーストラリアのバーチャル治験市場

第13章 インドネシアのバーチャル治験市場

第14章 韓国のバーチャル治験市場

第15章 西欧のバーチャル治験市場

第16章 英国のバーチャル治験市場

第17章 ドイツのバーチャル治験市場

第18章 フランスのバーチャル治験市場

第19章 東欧のバーチャル治験市場

第20章 ロシアのバーチャル治験市場

第21章 北米のバーチャル治験市場

第22章 米国のバーチャル治験市場

第23章 南米のバーチャル治験市場

第24章 ブラジルのバーチャル治験市場

第25章 中東のバーチャル治験市場

第26章 アフリカのバーチャル治験市場

第27章 バーチャル治験市場:競合情勢と企業プロファイル

  • バーチャル治験市場:競合情勢
  • バーチャル治験市場:企業プロファイル
    • ICON, plc
    • Parexel International
    • IQVIA
    • Covance
    • PRA Health Sciences

第28章 バーチャル治験市場における主要な企業合併・買収 (M&A)

第29章 バーチャル治験市場:将来展望と潜在力の分析

第30章 付録

目次
Product Code: h1921

“Virtual Clinical Trials Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global virtual clinical trials market.

This report focuses on virtual clinical trials market which is experiencing strong growth. The report gives a guide to the virtual clinical trials market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the virtual clinical trials? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Virtual Clinical Trials market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider virtual clinical trials market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The virtual clinical trials market section of the report gives context. It compares the virtual clinical trials market with other segments of the virtual clinical trials market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, virtual clinical trials indicators comparison.

Scope

Markets Covered:

  • 1) By Design: Observational Trials; Interventional Trials; Expanded Access Trials
  • 2) By Phases: Phase I; Phase II; Phase III; Phase IV
  • 3) By Indication: CNS; Autoimmune/Inflammation; Cardiovascular Disease; Metabolic/Endocrinology; Infectious Disease; Oncology; Genitourinary; Ophthalmology; Others
  • Companies Mentioned: ICON, plc; Parexel International; IQVIA; Covance; PRA Health Sciences
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Executive Summary

Major players in the virtual clinical trials market are: ICON, plc, Parexel International, IQVIA, Covance, PRA Health Sciences, LEO Innovation Lab, Medidata, Oracle Inc., CRF Health, Clinical Ink, Inc., Medable, Inc., Signant Health, Thread Research, Halo Health Systems, and Croprime.

The global virtual clinical trials market is expected to grow from $8.85 billion in 2021 to $9.61 billion in 2022 at a compound annual growth rate (CAGR) of 8.68%. The virtual clinical trials market is expected to grow to $12.96 billion in 2026 at a compound annual growth rate (CAGR) of 7.75%.

The virtual clinical trials market consists of sales of virtual clinical trials solutions and related services by entities (organizations, sole traders, and partnerships) that refers to remote or decentralized clinical trials or studies that incorporate digital health technologies and enable remote participation outside the traditional brick-and-mortar clinical trial site using tablets, smartphone apps, or wearable sensors. Virtual clinical trials allow significant digital changes in clinical research methodology, resulting in a more patient-centric ecosystem. These solutions consider many technological advantages, including innovative applications, electronic devices, online social engagement platforms, artificial intelligence, robotic process automation, machine learning, and others.

The main design types of virtual clinical trials include observational trials, interventional trials, and expanded access trials. The observational trials refer to virtual clinical trials solutions and services used in the observational trials. Observational studies aim to learn what occurs to people in various contexts. The study team observes the participants but does not influence the therapies they get. The virtual clinical trials are used in Phase I, Phase II, Phase III, and Phase IV, and they are used in clinical trials of drugs are devices used in the treatment of CNS, autoimmune/inflammation, cardiovascular diseases, metabolic/endocrinology, infectious diseases, oncology, genitourinary, ophthalmology, and others.

North America was the largest region in the virtual clinical trials market in 2021. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virtual clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The virtual clinical trials market research report is one of a series of new reports from The Business Research Company that provides virtual clinical trials market statistics, including virtual clinical trials industry global market size, regional shares, competitors with a virtual clinical trials market share, detailed virtual clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the virtual clinical trials industry. This virtual clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The increasing investments by the government and pharmaceutical companies in the R&D for the development of new vaccines and drugs are driving the growth of the virtual clinical trials market. The R&D divisions in the medical industry are increasingly utilizing virtual clinical trial solutions and services to increase quality assurance and clinical data management of drugs and their products. For instance, according to the study published in Research!America, a non-profit medical and health research advisory, the medical and health R&D investment in the USA was recorded at $241.5 billion in 2020 an 11.1% increase from 2019. Additionally, in June 2021, an article published by Mckinsey, COVID-19 pandemic, has catalyzed the adoption of decentralized clinical trials by pharma companies while highlighting the critical benefits of virtual trials and improving the patient and physician experience. Therefore, the increasing investments by the government and pharmaceutical companies in new vaccines and drug development are driving the growth of virtual clinical trials.

Technology advancement is a key trend gaining popularity in the virtual clinical trials market. Major companies operating in the virtual clinical trials market are focused on providing technologically-advanced solutions to meet fast-growing industry demands and strengthen their market position. These companies are implementing new generation virtual clinical technologies into their services, such as wearable technologies, mHealth, blockchain, cloud computing, EMR integration, actionable data, threshold monitoring, AI, SFTP, ETL services, and others. For instance, In April 2022, Unlearn.AI, a US-based startup, will launch a new digital twin RCTs technology for clinical trials that enables smaller control groups while maintaining power and generating evidence suitable for supporting regulatory decisions using AI and historical data.

In August 2019, Water Street Health Partners and JLL Partners, USA-based private equity companies acquired Thread for an undisclosed amount. Through this acquisition, the equity partners are focused on increasing the customer base and business operation of Thread across the globe. Thread is a North Carolina-based company involved in offering virtual clinical trial solutions and services.

The countries covered in the virtual clinical trials market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Table of Contents

1. Executive Summary

2. Virtual Clinical Trials Market Characteristics

3. Virtual Clinical Trials Market Trends And Strategies

4. Impact Of COVID-19 On Virtual Clinical Trials

5. Virtual Clinical Trials Market Size And Growth

  • 5.1. Global Virtual Clinical Trials Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Virtual Clinical Trials Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Virtual Clinical Trials Market Segmentation

  • 6.1. Global Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Observational Trials
  • Interventional Trials
  • Expanded Access Trials
  • 6.2. Global Virtual Clinical Trials Market, Segmentation By Phases, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
  • 6.3. Global Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • CNS
  • Autoimmune/Inflammation
  • Cardiovascular Disease
  • Metabolic/Endocrinology
  • Infectious Disease
  • Oncology
  • Genitourinary
  • Ophthalmology
  • Others

7. Virtual Clinical Trials Market Regional And Country Analysis

  • 7.1. Global Virtual Clinical Trials Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global Virtual Clinical Trials Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Virtual Clinical Trials Market

  • 8.1. Asia-Pacific Virtual Clinical Trials Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 8.3. Asia-Pacific Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Virtual Clinical Trials Market

  • 9.1. China Virtual Clinical Trials Market Overview
  • 9.2. China Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
  • 9.3. China Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Virtual Clinical Trials Market

  • 10.1. India Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 10.2. India Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Virtual Clinical Trials Market

  • 11.1. Japan Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 11.2. Japan Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Virtual Clinical Trials Market

  • 12.1. Australia Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 12.2. Australia Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Virtual Clinical Trials Market

  • 13.1. Indonesia Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 13.2. Indonesia Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Virtual Clinical Trials Market

  • 14.1. South Korea Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 14.2. South Korea Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Virtual Clinical Trials Market

  • 15.1. Western Europe Virtual Clinical Trials Market Overview
  • 15.2. Western Europe Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 15.3. Western Europe Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Virtual Clinical Trials Market

  • 16.1. UK Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 16.2. UK Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Virtual Clinical Trials Market

  • 17.1. Germany Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 17.2. Germany Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Virtual Clinical Trials Market

  • 18.1. France Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 18.2. France Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Virtual Clinical Trials Market

  • 19.1. Eastern Europe Virtual Clinical Trials Market Overview
  • 19.2. Eastern Europe Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 19.3. Eastern Europe Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Virtual Clinical Trials Market

  • 20.1. Russia Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 20.2. Russia Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Virtual Clinical Trials Market

  • 21.1. North America Virtual Clinical Trials Market Overview
  • 21.2. North America Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 21.3. North America Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Virtual Clinical Trials Market

  • 22.1. USA Virtual Clinical Trials Market Overview
  • 22.2. USA Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 22.3. USA Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Virtual Clinical Trials Market

  • 23.1. South America Virtual Clinical Trials Market Overview
  • 23.2. South America Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 23.3. South America Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Virtual Clinical Trials Market

  • 24.1. Brazil Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 24.2. Brazil Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Virtual Clinical Trials Market

  • 25.1. Middle East Virtual Clinical Trials Market Overview
  • 25.2. Middle East Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 25.3. Middle East Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Virtual Clinical Trials Market

  • 26.1. Africa Virtual Clinical Trials Market Overview
  • 26.2. Africa Virtual Clinical Trials Market, Segmentation By Design, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 26.3. Africa Virtual Clinical Trials Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Virtual Clinical Trials Market Competitive Landscape And Company Profiles

  • 27.1. Virtual Clinical Trials Market Competitive Landscape
  • 27.2. Virtual Clinical Trials Market Company Profiles
    • 27.2.1. ICON, plc
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Parexel International
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. IQVIA
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Covance
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. PRA Health Sciences
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Virtual Clinical Trials Market

29. Virtual Clinical Trials Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer